Startseite/Aktien/RZLT

RZLT

USD

Rezolute Inc. Common Stock (NV)

$8.900-0.020 (-0.224%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$8.920

Hoch

$9.000

Tief

$8.820

Volumen

1.64M

Unternehmensfundamentaldaten

Marktkapitalisierung

808.4M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.24M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $2.215Aktuell $8.900Hoch $10.04

Ähnliche Nachrichten

29. Okt. 2025 · 16:02

Analyst Upgrades

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

Citizens analyst Jason N. Butler maintains Rezolute with a Market Outperform and raises the price target from $9 to $17.

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

15. Okt. 2025 · 12:00

GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Rezolute to Participate in Upcoming Investor Conferences

9. Okt. 2025 · 20:05

GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today